CLB4 Antibody

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology

  • Claudin-4 (CLDN4): A transmembrane protein critical for tight junction formation in epithelial cells, often overexpressed in cancers. Antibodies targeting CLDN4 are under investigation for cancer therapy .

  • Cyclin B4 (Clb4): A yeast protein regulating microtubule dynamics during mitosis. Research on Clb4 antibodies is limited, with one study detailing its role in spindle alignment .

This article focuses on Claudin-4 Antibodies, given their therapeutic relevance and extensive documentation.

Claudin-4 (CLDN4) Antibodies: Biological Role and Mechanisms

Claudin-4 is a tight junction protein overexpressed in cancers like colorectal, gastric, and bladder carcinomas. Antibodies targeting its extracellular domain disrupt tumor integrity and enhance drug penetration .

Key mechanisms of action:

  • Tight Junction Disruption: Anti-CLDN4 antibodies (e.g., 4D3, xi-5D12) impair tumor cell adhesion, increasing paracellular permeability for chemotherapeutics .

  • Antibody-Dependent Cellular Cytotoxicity (ADCC): Some antibodies (e.g., xi-5D12) activate immune-mediated tumor cell lysis .

  • Synergy with Targeted Therapies: Sequential treatment with anti-CLDN4 and anti-EGFR antibodies (e.g., cetuximab) enhances efficacy in colorectal cancer models .

Antitumor Efficacy

AntibodyModel SystemOutcomeSource
xi-5D12Colorectal/GastricTumor growth suppression without toxicity
4D3Colorectal MetastasisReduced metastatic spread via TJ disruption
MAB42191Prostate CancerCell surface and cytoplasmic staining

Research Applications

  • Immunohistochemistry (IHC): EP617 detects CLDN4 in colorectal adenocarcinoma .

  • Flow Cytometry: MAB4219 and FAB4219A enable surface CLDN4 detection in live cells .

  • Therapeutic Development: 4D3 enhances cetuximab penetration in 3D tumor spheroids .

Future Directions

  • Combination therapies: Pairing CLDN4 antibodies with checkpoint inhibitors (e.g., anti-CTLA-4) .

  • Biomarker development: CLDN4 overexpression correlates with metastasis, suggesting prognostic utility .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CLB4 antibody; YLR210W antibody; L8167.3 antibody; G2/mitotic-specific cyclin-4 antibody
Target Names
CLB4
Uniprot No.

Target Background

Function
CLB4 Antibody is essential for the control of the cell cycle at the G2/M (mitosis) transition. It interacts with the CDC2 protein kinase to form MPF. G2/M cyclins accumulate steadily during G2 and are abruptly destroyed at mitosis.
Database Links

KEGG: sce:YLR210W

STRING: 4932.YLR210W

Protein Families
Cyclin family, Cyclin AB subfamily

Q&A

What is CLB4 and why are antibodies against it important for research?

CLB4 (Cyclin B4) is a B-type cyclin in Saccharomyces cerevisiae that plays crucial roles in cell cycle regulation, particularly in controlling astral microtubule (aMT) dynamics during cell division. Research has identified CLB4 as an APC/C Cdc20 substrate whose degradation is required for aMT stabilization in anaphase . Antibodies against CLB4 are essential tools for studying cell cycle progression, protein degradation mechanisms, and microtubule dynamics in yeast.

How do CLB4 antibodies differ from antibodies against other cyclins?

CLB4 antibodies target specific epitopes of the CLB4 protein that distinguish it from other B-type cyclins (Clb1, Clb2, Clb3, Clb5, and Clb6). Unlike Clb2, whose degradation is mainly dependent on the APC/C Cdh1 complex, CLB4 degradation kinetics more closely resemble those of Pds1, a known APC/C Cdc20 substrate . Properly validated CLB4 antibodies should demonstrate minimal cross-reactivity with other cyclins, making them suitable for specific detection of CLB4-related events during cell cycle progression.

What are the main applications of CLB4 antibodies in cell cycle research?

CLB4 antibodies are primarily used in the following applications:

  • Western blotting to track CLB4 protein levels throughout the cell cycle

  • Immunoprecipitation to study CLB4 interactions with other proteins

  • Immunofluorescence to examine subcellular localization

  • Monitoring CLB4 degradation by the APC/C Cdc20 complex

  • Investigating CLB4's role in astral microtubule regulation

What methods are recommended for detecting CLB4 degradation during the cell cycle?

To effectively monitor CLB4 degradation:

  • Synchronize yeast cultures using hydroxyurea (HU) arrest, which arrests cells in S-phase

  • Release cells from arrest and collect samples at defined timepoints

  • Extract proteins using methods that preserve post-translational modifications

  • Perform western blot analysis with validated CLB4 antibodies

  • Compare CLB4 degradation kinetics with other known APC/C Cdc20 substrates such as Pds1

Research has shown that CLB4 protein levels remain high in cdc20 mutant cells but drop when cells enter anaphase in wild-type, cdc14 cdc5, and cdc15 cells, confirming its degradation pattern as an APC/C Cdc20 substrate .

How can I optimize western blot protocols for CLB4 detection?

For optimal CLB4 detection by western blot:

ParameterRecommendation
Sample preparationFresh whole cell extracts with protease/phosphatase inhibitors
Gel percentage10-12% SDS-PAGE for optimal resolution
Transfer conditionsLower voltage, longer time for complete transfer
Blocking solution5% non-fat milk or BSA in TBST
Primary antibody1:1000 to 1:5000 dilution, incubate at 4°C for 12h
Positive controlSynchronized cells at metaphase
Negative controlclb4Δ strains

Researchers have successfully used these parameters to track CLB4 levels in synchronous cell cycle experiments and in cells with altered Cdc20 expression .

What controls are essential when using CLB4 antibodies in research?

Essential controls for CLB4 antibody experiments include:

  • Genetic controls: Include clb4Δ strains to confirm antibody specificity

  • Cell cycle controls: Use synchronized cells at known cell cycle stages

  • Related protein controls: Compare with other cyclins (e.g., Clb2) to demonstrate specificity

  • Loading controls: Use stable proteins unaffected by cell cycle

  • Epitope competition: Perform peptide competition assays to validate specificity

Studies examining CLB4 as an APC/C Cdc20 substrate utilized S-phase arrested cells with hydroxyurea as controls, along with comparisons to Pds1 and Clb2 degradation patterns .

How are CLB4 antibodies used to study APC/C Cdc20-mediated degradation?

To study APC/C Cdc20-mediated degradation of CLB4:

  • Generate strains with various APC/C or Cdc20 mutations (e.g., cdc20 temperature-sensitive alleles)

  • Arrest cells at specific cell cycle stages (e.g., S-phase with hydroxyurea)

  • Induce Cdc20 expression using inducible promoters (e.g., GAL-CDC20)

  • Monitor CLB4 levels by western blot

  • Compare degradation kinetics with known APC/C Cdc20 substrates

Research has demonstrated that in S-phase arrested cells, high levels of Cdc20 lead to rapid CLB4 degradation, while Clb2 remains stable, confirming CLB4 as an APC/C Cdc20 substrate .

What approaches can be used to study CLB4's role in astral microtubule dynamics?

To investigate CLB4's function in astral microtubule regulation:

  • Compare aMT length and stability in wild-type vs. various mutant strains

  • Perform immunofluorescence to co-localize CLB4 with microtubule components

  • Use live-cell imaging of GFP-tagged tubulin in CLB4 mutant backgrounds

  • Correlate CLB4 degradation timing with changes in aMT dynamics

  • Examine synthetic genetic interactions between CLB4 and microtubule-associated proteins

Studies have shown that deletion of CLB4 in a cdc20 background leads to abnormally stable metaphase aMTs, resembling the phenotype of esp1 cdc15 cells, which indicates CLB4's specialized role in aMT regulation compared to other cyclins .

Why might my CLB4 antibody show inconsistent results across experiments?

Inconsistent results with CLB4 antibodies could be due to:

IssuePossible CauseSolution
Variable signal intensityCell cycle asynchronyImprove synchronization protocols
Multiple bandsDegradation productsAdd complete protease inhibitor cocktail
Weak or no signalEpitope maskingTry different extraction buffers
Background bandsCross-reactivityValidate with clb4Δ controls
Inconsistent loadingSample preparationStandardize protein extraction method

Research on CLB4 degradation has demonstrated the importance of carefully synchronized cultures and proper controls when monitoring this cell cycle-regulated protein .

How can I validate the specificity of a CLB4 antibody?

To validate CLB4 antibody specificity:

  • Perform western blots comparing wild-type and clb4Δ strains

  • Test reactivity against recombinant CLB4 protein

  • Conduct peptide competition assays

  • Verify expected molecular weight and cell cycle-dependent expression pattern

  • Check for cross-reactivity with other B-type cyclins

Researchers validating CLB4 as an APC/C Cdc20 substrate confirmed antibody specificity by observing expected degradation patterns and molecular weight, with comparative analysis against other cyclins like Clb2 .

How are CLB4 antibodies being used to study mitotic checkpoint mechanisms?

Current research applications include:

  • Investigating CLB4's role in spindle assembly checkpoint signaling

  • Examining the relationship between CLB4 degradation and anaphase onset

  • Studying how CLB4-CDK activity regulates microtubule-cortex interactions

  • Analyzing synthetic genetic interactions between CLB4 and checkpoint components

  • Investigating CLB4's unique function in astral microtubule stabilization

Recent findings highlight that CLB4 has a specialized role among cyclin subunits, as its degradation by APC/C Cdc20 is specifically required for proper aMT stabilization during anaphase .

What innovative techniques combine CLB4 antibodies with advanced imaging methods?

Cutting-edge approaches include:

  • Super-resolution microscopy to visualize CLB4 localization at microtubule plus ends

  • Live-cell imaging using fluorescently tagged proteins to correlate with CLB4 levels

  • FRAP (Fluorescence Recovery After Photobleaching) to study CLB4 dynamics

  • Proximity ligation assays to detect CLB4 interactions with specific proteins in situ

  • Correlative light and electron microscopy to examine CLB4's role in microtubule ultrastructure

These techniques have helped researchers understand how CLB4-Cdk1 controls the interaction of astral microtubule plus ends with cortical capture sites during cell division .

How does CLB4 degradation compare with other APC/C Cdc20 substrates?

The timing and mechanism of CLB4 degradation show distinctive characteristics:

ProteinDegradation TimingPrimary Degradation PathwayKey Features
CLB4Early anaphaseAPC/C Cdc20Resembles Pds1 degradation pattern
Pds1Early anaphaseAPC/C Cdc20Canonical APC/C Cdc20 substrate
CLB2Late anaphase/telophasePrimarily APC/C Cdh1Partially degraded in anaphase
Kip1Metaphase/anaphaseAPC/C Cdc20Motor protein, partial effect on aMTs
Acm1AnaphaseAPC/C Cdc20APC/C Cdh1 inhibitor

Research has shown that CLB4 degradation kinetics closely resemble those of Pds1, differentiating it from CLB2, which shows delayed degradation and is only partially degraded in anaphase-arrested cells .

What is the specific role of CLB4 compared to other B-type cyclins in yeast?

CLB4 has a unique and specialized function among cyclin subunits:

  • CLB4 is specifically involved in astral microtubule stabilization

  • Deletion of CLB4, but not other cyclins, significantly alters aMT length and number

  • CLB4-Cdk1 activity regulates the interaction of astral microtubule plus ends with cortical capture sites

  • CLB4 degradation by APC/C Cdc20 is required for proper spindle positioning and orientation

  • While other cyclins may have overlapping functions, CLB4's role in aMT dynamics appears to be unique

These findings highlight that CLB4 has a specialized function that distinguishes it from other B-type cyclins in yeast cell cycle regulation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.